Related Experiment Video
Updated: Dec 8, 2025

Author Spotlight: Unveiling the Role of SNF2L in Replication Fork Stability and Genome Duplication
Published on: August 23, 2024
PCAF-Mediated Histone Acetylation Promotes Replication Fork Degradation by MRE11 and EXO1 in BRCA-Deficient Cells
Jae Jin Kim1, Seo Yun Lee1, Ji-Hye Choi2
1Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
Abstract:
Stabilization of stalled replication forks is a prominent mechanism of PARP (Poly(ADP-ribose) Polymerase) inhibitor (PARPi) resistance in BRCA-deficient tumors. Epigenetic mechanisms of replication fork stability are emerging but remain poorly understood. Here, we report the histone acetyltransferase PCAF (p300/CBP-associated) as a fork-associated protein that promotes fork degradation in BRCA-deficient cells by acetylating H4K8 at stalled replication forks, which recruits MRE11 and EXO1. A H4K8ac binding domain within MRE11/EXO1 is required for their recruitment to stalled forks. Low PCAF levels, which we identify in a subset of BRCA2-deficient tumors, stabilize stalled forks, resulting in PARPi resistance in BRCA-deficient cells. Furthermore, PCAF activity is tightly regulated by ATR (ataxia telangiectasia and Rad3-related), which phosphorylates PCAF on serine 264 (S264) to limit its association and activity at stalled forks. Our results reveal PCAF and histone acetylation as critical regulators of fork stability and PARPi responses in BRCA-deficient cells, which provides key insights into targeting BRCA-deficient tumors and identifying epigenetic modulators of chemotherapeutic responses.
Insights
Poly(ADP-ribose) Polymerase (PARP) inhibitor resistance in BRCA-deficient tumors involves replication fork stability. The study identifies PCAF histone acetyltransferase as a key regulator, influencing fork degradation and PARPi response.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Research
Background:
- PARP inhibitor (PARPi) resistance in BRCA-deficient tumors is often linked to replication fork stabilization.
- Epigenetic regulation of replication fork stability is an emerging area with limited understanding.
Purpose of the Study:
- To investigate the role of epigenetic mechanisms, specifically histone acetylation, in regulating replication fork stability and PARPi resistance.
- To identify novel proteins involved in replication fork stability in BRCA-deficient cells.
Main Methods:
- Identified PCAF as a fork-associated protein using biochemical assays.
- Investigated the acetylation of H4K8 at stalled replication forks and its effect on MRE11 and EXO1 recruitment.
- Analyzed PCAF levels in BRCA2-deficient tumors.
- Studied the regulation of PCAF activity by ATR-mediated phosphorylation.
Main Results:
- PCAF promotes replication fork degradation in BRCA-deficient cells by acetylating H4K8, recruiting MRE11 and EXO1.
- A specific binding domain in MRE11/EXO1 is crucial for their recruitment to stalled forks.
- Reduced PCAF levels stabilize stalled forks, leading to PARPi resistance in BRCA-deficient cells.
- ATR phosphorylates PCAF at S264, limiting its activity at stalled forks.
Conclusions:
- PCAF and H4K8 acetylation are critical regulators of replication fork stability and PARPi response in BRCA-deficient cells.
- Targeting PCAF or epigenetic modulators could offer new therapeutic strategies for BRCA-deficient tumors.
- Understanding these mechanisms provides insights into overcoming chemotherapeutic resistance.
Related Concept Videos
Restarting Stalled Replication Forks
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The DNA Replication Fork
Long-patch Base Excision Repair
Homologous Recombination

